Skip to Content

TEVA 7032 (Mycophenolic Acid Delayed-Release 360 mg)

Pill with imprint TEVA 7032 is Orange, Capsule-shape and has been identified as Mycophenolic Acid Delayed-Release 360 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Mycophenolic acid is used in the treatment of rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7032

Mycophenolic acid delayed-release 360 mg TEVA 7032

Mycophenolic Acid Delayed-Release

Imprint
TEVA 7032
Strength
360 mg
Color
Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7032

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.